Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials

J Am Coll Cardiol. 2006 Feb 7;47(3):685-6. doi: 10.1016/j.jacc.2005.11.018. Epub 2006 Jan 18.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Combined Modality Therapy
  • Electrocardiography
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab